https://merakris.com/new-innovations-in-venous-leg-ulcer-treatments-whats-on-the-horizon/ 2024-01-15T21:31:37+00:00 https://merakris.com/wp-content/uploads/2024/01/lateral-wound.png https://merakris.com/merakris-to-share-data-from-fully-enrolled-first-part-of-two-part-dermacyte-liquid-clinical-trial/ 2024-02-20T15:42:15+00:00 https://merakris.com/merakris-announces-nationwide-at-your-door-autologous-serum-tears-program/ 2024-02-20T15:45:48+00:00 https://merakris.com/wound-healing-technology-company-merakris-adds-two-executives-to-leadership-team/ 2024-02-20T15:54:45+00:00 https://merakris.com/a-new-frontier-in-healing-chronic-wounds-a-breakthrough-injectable-therapy/ 2024-02-20T18:27:47+00:00 https://merakris.com/wp-content/uploads/2024/01/5yearmortality.png https://merakris.com/wp-content/uploads/2024/01/wound-care.png https://merakris.com/merakris-ceo-to-discuss-dermacyte-development-program-as-part-of-advanced-wound-care-summit-panel-in-july/ 2024-02-20T18:29:05+00:00 https://merakris.com/merakris-therapeutics-to-release-final-part-1-data-from-phase-2-multicenter-investigational-drug-study-for-dermacyte-liquid/ 2024-02-21T18:28:23+00:00 https://merakris.com/favorable-results-from-dermacyte-matrix-research-study-published-in-march-issue-of-journal-of-wound-care/ 2024-05-09T10:36:31+00:00 https://merakris.com/jonathan-berlent-joins-merakris-as-svp-head-of-strategy-and-operations/ 2024-05-09T10:36:55+00:00 https://merakris.com/merakris-therapeutics-announces-fda-clearance-for-part-2-of-its-phase-ii-multicenter-investigational-new-drug-study-of-dermacyte-liquid/ 2024-09-23T13:06:55+00:00 https://merakris.com/merakris-therapeutics-introduces-dermacyte-ac-matrix-a-lyophilized-amnion-chorion-allograft/ 2024-10-01T12:21:36+00:00 https://merakris.com/merakris-therapeutics-announces-open-enrollment-for-phase-ii-clinical-trial-of-subcutaneous-injection-drug-for-the-treatment-of-vlu/ 2024-12-10T12:08:48+00:00 https://merakris.com/2025-camps-summit-selects-merakris-therapeutics-scientist-with-inaugural-best-comparative-trial-award/ 2025-03-04T11:37:59+00:00 https://merakris.com/international-wound-journal-publishes-positive-phase-2-interim-data-on-cell-free-amniotic-fluid-injectable-biologic-for-the-treatment-of-venous-leg-ulcers/ 2025-03-26T16:47:51+00:00 https://merakris.com/merakris-therapeutics-appoints-roger-ilagan-to-chief-scientific-officer/ 2025-04-10T18:39:03+00:00 https://merakris.com/merakris-therapeutics-snced-wound-care-summit-innoelected-as-finalist-for-2025-advavation-showcase/ 2025-07-15T13:35:33+00:00 https://merakris.com/merakris-ind-mtx-001-wins-innovation-showcase-at-2025-advanced-wound-care-summit/ 2025-07-30T16:25:20+00:00 https://merakris.com/merakris-receives-uspto-notice-of-allowance-for-foundational-patent-supporting-mtx-001/ 2025-08-19T11:21:11+00:00 https://merakris.com/merakris-30th-subject-expanded-acess-program-mtx-001/ 2025-09-04T14:07:17+00:00 https://merakris.com/merakris-therapeutics-secures-fda-agreement-for-type-c-meeting-to-advance-mtx-001-development-pathway/ 2025-09-30T06:30:26+00:00 https://merakris.com/merakris-announces-completion-of-type-c-meeting-with-fda/ 2025-12-05T14:08:36+00:00 https://merakris.com/merakris-chief-scientific-officer-roger-ilagan-at-innovations-in-wound-healing-symposium/ 2025-12-11T18:56:55+00:00 https://merakris.com/fda-update-and-mtx-001-interim-findings-sawc-spring-26/ 2026-04-07T19:20:55+00:00 https://merakris.com/fda-grants-fast-track-designation-to-merakris-mtx-001-opening-potential-accelerated-path-to-market-for-venous-leg-ulcer-therapy/ 2026-06-02T14:38:49+00:00 https://merakris.com/merakris-therapeutics-awarded-u-s-department-of-veterans-affairs-federal-supply-schedule-contract-expanding-federal-market-access-for-dermacyte-ac-matrix-amniotic-membrane-allograft/ 2026-06-17T12:42:51+00:00 https://merakris.com/merakris-ifyber-receive-top-sawc-2026-award-mtx-001/ 2026-07-20T21:44:20+00:00 https://merakris.com/merakris-therapeutics-awarded-nih-direct-to-phase-ii-sbir-grant-to-advance-mtx-001-for-diabetic-foot-ulcers/ 2026-07-21T12:47:45+00:00 https://merakris.com/merakris-therapeutics-announces-amniosurge-asg/ 2026-09-08T12:34:51+00:00 https://merakris.com/merakris-advances-potentially-pivotal-mtx-001-phase-2-3-strategy-following-fda-pre-ind-meeting/ 2026-10-27T13:28:25+00:00